Oral Sedation During Cervical Dilator Placement

Completed · Phase 4 · Has a placebo group

Conditions studied: Oral Sedation and Cervical Dilator Pain

In brief

This will be a randomized, double-blind, placebo-controlled trial involving 2 arms. It will be comparing the effects of placebo compared to 1 mg oral lorazepam/5 mg oral oxycodone on pain scores during cervical dilator placement prior to dilation and evacuation (D\&E).

Key facts

Study ID

NCT03202550

Run by

Johns Hopkins University

People needed

27

Starts

2017-06-28

Expected to finish

2019-05-28

Last updated by the study team

2020-03-30

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women aged 18-50 years
• English speaking
• With an intrauterine pregnancy (either viable or non-viable) between the gestational ages of 17w0d and 23w6d
• Have a support person present with participant
• Have a cell phone capable of text messaging (optional)

You may not qualify if…

• Non-English-speaking
• Taking a daily benzodiazepine or opiate
• Have a known allergy or contraindication to NSAIDs, opiates, or benzodiazepines

Where it is running

• Johns Hopkins' Women's Center for Family Planning — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.